Skip to main content
MedPathMedPath Home
Clinical Trials/NL-OMON32809
NL-OMON32809
Completed
Not Applicable

[18F]-Fluorodeoxyglucose Positron Emission Tomography in Lung Tumour Assessment, Research into Characteristics - PLuTARCh

niversitair Medisch Centrum Sint Radboud0 sites54 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
Conditionslung cancernon-small cell lung carcinoma1003866610029107

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
lung cancer
Sponsor
niversitair Medisch Centrum Sint Radboud
Enrollment
54
Status
Completed
Last Updated
last year
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Observational invasive

Investigators

Sponsor
niversitair Medisch Centrum Sint Radboud

Eligibility Criteria

Inclusion Criteria

  • •Adult patients (age 18 years and over) with:
  • •\-Newly diagnosed or suspected NSCLC stage IB, IIB or limited stage III (T3N1\) (at least 30mm in smallest diameter);
  • •\-Primary surgical resection (wedge excision, segmentectomy, lobectomy or pneumonectomy).

Exclusion Criteria

  • •\- Neoadjuvant treatment prior to surgery;
  • •\- No staging CT or FDG\-PET available;
  • •\- Contra\-indication for surgery:
  • •o Based on (biological) age, cardiovascular risk factors, expected remaining lung function, performance status or other co\-morbidity as decided by a multidisciplinary team including medical oncologists, thorax surgeons, pulmonologists, radiation oncologists, pathologists, radiologists and nuclear medicine physicians.
  • •\- Contra\-indication for dynamic FDG\-PET:
  • •o Diabetes mellitus;
  • •o Pregnancy;
  • •o Breast\-feeding;
  • •o Severe claustrophobia.
  • •o Post\-obstruction pneumonia (false\-positive FDG\-PET)

Outcomes

Primary Outcomes

Not specified

Similar Trials

Recruiting
Not Applicable
[18F]-Fluorodeoxyglucose Positron Emission Tomography for In Vivo Assessment of Glucose Metabolism in Pheochromoctyoma and Paragangliomaadrenal tumours1002911210014710
NL-OMON38518niversitair Medisch Centrum Sint Radboud25
Recruiting
Not Applicable
FDG PET CT role in High risk renal cancer and Bladder cancer
CTRI/2022/07/043691AIIMS Jodhpur
Active, not recruiting
Not Applicable
Combined 18F-Fluorodeoxyglucose (FDG) Positron Emission Tomography (PET) and Metomidate Imaging for Adrenal Neoplasia (FAMIAN-Study) - a Diagnostic Studyindeterminate adrenal neoplasiasTherapeutic area: Analytical, Diagnostic and Therapeutic Techniques and Equipment [E] - Diagnosis [E01]
EUCTR2012-003604-13-DEniversity Hospital Wuerzburg220
Recruiting
Not Applicable
*The use of 18F-fluorodeoxyglucose positron emission tomography and computed tomography imaging for the detection of inflammation in steatotic livers as an indicator of non-alcoholic steatohepatitis*
NL-OMON32768Vrije Universiteit Medisch Centrum16
Completed
Not Applicable
Fluorodeoxyglucose-positron emission tomography for avoidance of futile direct laryngoscopies under general anaesthesia with taking of biopsies in patients with suspicion on recurrent laryngeal carcinoma after radiotherapyaryngeal carcinomaCancerLaryngeal cancer
ISRCTN89530459Vrije University Medical Centre (VUMC) (The Netherlands)150